Incidental Diagnosis of Rheumatic Myocarditis during Cardiac Surgery-Impact on Late Prognosis
Carregando...
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
MDPI
Citação
DIAGNOSTICS, v.13, n.20, article ID 3252, 10p, 2023
Resumo
Rheumatic fever (RF) and rheumatic heart disease (RHD) are still highly prevalent, particularly in low- and middle-income countries. RHD is a neglected and underdiagnosed disease for which no specific laboratory diagnostic test is completely reliable. This is a retrospective observational study, which included 118 patients with RHD who underwent cardiac surgery from 1985 to 2018. The aim of this investigation was to evaluate the clinical, epidemiological, echocardiographic and pathological characteristics in two cohorts of RHD patients: one cohort with Aschoff bodies present in their pathological results and the other without such histopathological characteristics. No conventional clinical and laboratory tests for RHD myocarditis were able to identify active carditis during the preoperative phase of valve repair or replacement. Patients who had Aschoff bodies in their pathological results were younger (median age of 13 years (11-24 years) vs. 27 years (17-37 years), p = 0.001) and had higher rate of late mortality (22.9% vs. 5.4%, p = 0.043). In conclusion, the presence of Aschoff bodies in pathological findings may predict increased long-term mortality, emphasizing the importance of comprehensive pathology analysis for suspected myocarditis during heart surgery.
Palavras-chave
rheumatic fever, diagnosis, Aschoff body, pathology, surgery
Referências
- Abdel-Aty H, 2005, J AM COLL CARDIOL, V45, P1815, DOI 10.1016/j.jacc.2004.11.069
- Bhardwaj Rajeev, 2015, J Assoc Physicians India, V63, P22
- Brown A, 2007, MED J AUSTRALIA, V186, P557, DOI 10.5694/j.1326-5377.2007.tb01052.x
- Buonacera A, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23073636
- Calegaro J U, 1991, Arq Bras Cardiol, V56, P487
- Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028
- Costa Luciana Parente, 2009, Rev. Bras. Reumatol., V49, P617, DOI 10.1590/S0482-50042009000500010
- Branco CED, 2016, ARQ BRAS CARDIOL, V107, P482, DOI 10.5935/abc.20160150
- Ferri C, 2022, CURR PHARM DESIGN, V28, P2022, DOI 10.2174/1381612828666220614151732
- Fraser WJ, 1997, HISTOPATHOLOGY, V31, P460, DOI 10.1046/j.1365-2559.1997.2990883.x
- Gross L, 1934, AM J PATHOL, V10, P489
- GUADALAJARA J F, 1990, Archivos del Instituto de Cardiologia de Mexico, V60, P541
- Guilherme L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00352
- Javadi H, 2011, NUCL MED REV, V14, P112, DOI 10.5603/NMR.2011.00026
- Kumar RK, 2020, CIRCULATION, V142, pE337, DOI 10.1161/CIR.0000000000000921
- Lue HC, 1996, PEDIATRICS, V97, P984
- Marijon E, 2007, NEW ENGL J MED, V357, P470, DOI 10.1056/NEJMoa065085
- MURPHY GE, 1952, J EXP MED, V95, P319, DOI 10.1084/jem.95.3.319
- Pirinççioglu AG, 2012, TURK KARDIYOL DERN A, V40, P427, DOI 10.5505/tkda.2012.87405
- Ralph AP, 2021, MED J AUSTRALIA, V214, P220, DOI 10.5694/mja2.50851
- Regolo M, 2023, J CLIN MED, V12, DOI 10.3390/jcm12124057
- Reina-Couto M, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.746494
- Reményi B, 2012, NAT REV CARDIOL, V9, P297, DOI 10.1038/nrcardio.2012.7
- ROBERTS WC, 1978, CIRCULATION, V57, P803, DOI 10.1161/01.CIR.57.4.803
- Rosa VEE, 2015, J HEART VALVE DIS, V24, P629
- Sampaio RO, 2007, VASC HEALTH RISK MAN, V3, P1007
- Sheikh Abdul Malik, 2016, J Ayub Med Coll Abbottabad, V28, P141
- Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950
- Spina GS, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00126
- VIRMANI R, 1977, CIRCULATION, V55, P559, DOI 10.1161/01.CIR.55.4.559
- Watkins DA, 2017, NEW ENGL J MED, V377, P713, DOI 10.1056/NEJMoa1603693
- Younis A, 2020, AM J MED, V133, P492, DOI 10.1016/j.amjmed.2019.10.015